IRIS
BONI, CAROLINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.184
AS - Asia 2.982
EU - Europa 1.654
SA - Sud America 428
AF - Africa 162
Continente sconosciuto - Info sul continente non disponibili 124
OC - Oceania 13
Totale 8.547
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.065
SG - Singapore 963
CN - Cina 655
IT - Italia 558
VN - Vietnam 552
BR - Brasile 336
IE - Irlanda 235
HK - Hong Kong 226
BD - Bangladesh 208
DE - Germania 187
SE - Svezia 170
FR - Francia 124
ZA - Sudafrica 104
TR - Turchia 86
NL - Olanda 81
CA - Canada 76
FI - Finlandia 74
IN - India 63
RU - Federazione Russa 46
GB - Regno Unito 41
KR - Corea 35
AR - Argentina 34
JP - Giappone 32
MX - Messico 24
IQ - Iraq 22
CI - Costa d'Avorio 18
AT - Austria 17
ID - Indonesia 16
PK - Pakistan 16
UA - Ucraina 14
UZ - Uzbekistan 14
BE - Belgio 13
CO - Colombia 13
PH - Filippine 13
AU - Australia 12
LT - Lituania 12
EC - Ecuador 11
MA - Marocco 11
TW - Taiwan 11
DK - Danimarca 10
ES - Italia 10
PL - Polonia 10
TH - Thailandia 10
VE - Venezuela 10
KE - Kenya 9
SA - Arabia Saudita 9
CZ - Repubblica Ceca 8
MY - Malesia 8
PY - Paraguay 7
CH - Svizzera 6
AE - Emirati Arabi Uniti 5
BG - Bulgaria 5
EG - Egitto 5
IR - Iran 5
RO - Romania 5
UY - Uruguay 5
AL - Albania 4
AZ - Azerbaigian 4
CL - Cile 4
CR - Costa Rica 4
IL - Israele 4
JM - Giamaica 4
JO - Giordania 4
LV - Lettonia 4
PE - Perù 4
PT - Portogallo 4
TN - Tunisia 4
BO - Bolivia 3
GT - Guatemala 3
DZ - Algeria 2
ET - Etiopia 2
GE - Georgia 2
GR - Grecia 2
HN - Honduras 2
KG - Kirghizistan 2
KH - Cambogia 2
KZ - Kazakistan 2
LU - Lussemburgo 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
RS - Serbia 2
TZ - Tanzania 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
CM - Camerun 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
HR - Croazia 1
HU - Ungheria 1
JE - Jersey 1
KW - Kuwait 1
LB - Libano 1
MD - Moldavia 1
ME - Montenegro 1
Totale 8.411
Salva come PNG Salva come JPEG
Città #
Singapore 491
Dallas 417
Ashburn 376
San Jose 356
Santa Clara 279
Dublin 234
Hong Kong 210
Chandler 177
Ho Chi Minh City 154
Parma 148
Beijing 143
Hanoi 139
New York 121
Council Bluffs 119
Boardman 108
Johannesburg 95
Los Angeles 85
Munich 85
Dearborn 79
Shanghai 70
Milan 69
Izmir 65
Ann Arbor 55
Lauterbourg 51
Buffalo 42
São Paulo 37
Hefei 34
Nanjing 34
Princeton 34
Haiphong 32
Wilmington 32
Turku 28
Rome 27
Toronto 27
Columbus 26
Frankfurt am Main 26
Bologna 25
Chicago 25
Moscow 23
Da Nang 22
Montreal 22
Tokyo 22
Abidjan 18
Houston 18
Rio de Janeiro 18
Shenyang 18
The Dalles 18
Nuremberg 17
Reggio Emilia 16
Guangzhou 15
Seattle 15
Seoul 15
Grafing 14
Helsinki 14
Hải Dương 14
London 14
Nanchang 14
Brussels 13
Hebei 13
Jacksonville 13
Phoenix 13
Tashkent 13
Baghdad 11
Bremen 11
Changsha 11
Naples 11
Orem 11
Vienna 11
Brooklyn 10
Curitiba 10
Denver 10
Düsseldorf 10
San Francisco 10
Bengaluru 9
Can Tho 9
Jakarta 9
Limena 9
Hangzhou 8
Modena 8
Montespertoli 8
Nairobi 8
Taastrup 8
Tianjin 8
Warsaw 8
Zhengzhou 8
Bangkok 7
Boston 7
Chennai 7
Jinan 7
Mexico City 7
Ottawa 7
Atlanta 6
Biên Hòa 6
Charlotte 6
Dhaka 6
Istanbul 6
Jiaxing 6
Kuala Lumpur 6
Norwalk 6
Paris 6
Totale 5.259
Salva come PNG Salva come JPEG
Nome #
FUNCTIONAL AND TRANSCRIPTIONAL RESTORATION OF EXHAUSTED VIRUS-SPECIFIC T LYMPHOCYTES FROM PATIENTS WITH CHRONIC HEPATITIS B 327
A novel enhancing effect of SARS-CoV-2 mutations on anti-viral CD8 T cell responses 324
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection 284
HBcrAg values may predict virological and immunological responses to pegIFN-α in NUC-suppressed HBeAg-negative chronic hepatitis B 257
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 213
TLR7 Agonist Increases Responses of Hepatitis B Virus–Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues 208
Therapeutic potential of co-signaling receptor modulation in hepatitis B 197
Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutations 188
Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic Approaches 187
Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B 183
Metabolic regulation of the HBV-specific T cell function 180
Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B 178
Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis 159
Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection 159
Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B 158
PeptiVAX: A new adaptable peptides-delivery platform for development of CTL-based, SARS-CoV-2 vaccines 156
Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection 156
Antiviral CD8-mediated responses in chronic HCV carriers with HBV superinfection 153
Degenerate CD8 Epitopes Mapping to Structurally Constrained Regions of the Spike Protein: A T Cell-Based Way-Out From the SARS-CoV-2 Variants Storm 152
HBV immune-therapy: From molecular mechanisms to clinical applications 150
The good and the bad of natural killer cells in virus control: Perspective for anti-HBV therapy 148
T cell regulation in HBV-related chronic liver disease 146
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro 143
Antigen Load and T Cell Function: A Challenging Interaction in HBV Infection 139
Targeting Stress Sensor Kinases in Hepatocellular Carcinoma-Infiltrating Human NK Cells as a Novel Immunotherapeutic Strategy for Liver Cancer 137
Early kinetics of innate and adaptive immune responses during hepatitis B virus infection 137
Unraveling the multifaceted nature of cd8 t cell exhaustion provides the molecular basis for therapeutic t cell reconstitution in chronic hepatitis b and c 136
What Is the Current Status of Hepatitis B Virus Viro-Immunology? 134
Increased levels of arginase in patients with acute hepatitis B suppress antiviral T cells 122
Functional reconstitution of HBV-specific CD8 T cells by in vitro polyphenol treatment in chronic hepatitis B 122
Strategies to overcome HBV-specific T cell exhaustion: checkpoint inhibitors and metabolic re-programming 120
Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens 120
The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection 119
FluoroSpot assay to analyze SARS-CoV-2-specific T cell responses 119
Contribution of herpesvirus specific CD8 T cells to anti-viral T cell response in humans 118
Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection 116
Conserved hepatitis C virus sequences are highly immunogenic for CD4+ T cells: Implications for vaccine development 111
Comparative pathogenesis of HBV and HCV 110
Comment on ‘End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB’ 110
Mobilizing monocytes to cross-present circulating viral antigen in chronic infection 108
Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C 108
Antiviral cell-mediated immune responses during hepatitis B and hepatitis C virus infections 106
Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B 105
The Characteristics of the Cell-Mediated Immune Response Identify Different Profiles of Occult Hepatitis B Virus Infection 102
High CD49a+ NK cell infiltrate is associated with poor clinical outcomes in Hepatocellular Carcinoma 100
Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B 100
Effector CD8(+) T cell-derived interleukin-10 enhances acute liver immunopathology 99
Editorial: Epigenetic and metabolic regulation of immunity during infection or cancer and associated immune biomarkers 97
Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections 96
Hepatitis B virus specific immune response: From antigen recognition to liver damage 91
Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: New perspectives for immune therapy 89
Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B 89
Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues 88
The scientific basis of combination therapy for chronic hepatitis B functional cure 87
T and NK Cell-Based Immunotherapy in Chronic Viral Hepatitis and Hepatocellular Carcinoma 86
Molecular features of the hepatitis B virus nucleocapsid T-cell epitope 18-27: interaction with HLA and T-cell receptor 85
TGF-β-driven NK Cells plasticity in hepatocellular carcinoma 83
Immunopathogenesis of hepatitis C virus infection 81
T cell receptor usage of virus-specific CD8 cells and recognition of viral mutations during acute and persistent hepatitis B virus infection 77
Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire 63
Immunopathogenesis of hepatitis B 61
Transcriptional and functional HBV-specific CD8 T cell changes from disease to functional cure in HBeAg-negative chronic hepatitis B 61
HBV antigens quantity: duration and effect on functional cure 60
Sex-based differences in hepatitis delta virus infection: Insights from the Italian PITER hepatitis delta virus cohort 18
Temporal transcriptional dynamics in HBV-specific CD8 T cells during long-term NUC therapy in HBeAg- chronic hepatitis B 17
Dysregulated transcription in core- and pol-specific CD8 T cells can be targeted by HDAC inhibition to improve T-cell function in chronic hepatitis B 14
Totale 8.547
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.188
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.188
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022190 0 4 3 26 20 21 11 13 13 4 11 64
2022/2023771 82 66 42 49 58 78 15 40 258 6 40 37
2023/2024548 27 49 27 52 31 119 56 28 25 35 37 62
2024/20251.912 63 91 102 127 200 234 110 127 232 136 163 327
2025/20264.197 348 568 390 296 470 210 405 138 601 303 211 257
2026/2027267 141 126 0 0 0 0 0 0 0 0 0 0
Totale 8.547